Dianthus Therapeutics (DNTH) Treasury Shares (2017 - 2022)

Dianthus Therapeutics' Treasury Shares history runs 7 years deep, the most recent figure standing at $63.0 for Q3 2023.

• In Q3 2023, Treasury Shares changed N/A year-over-year to $63.0; the TTM figure through Sep 2023 stood at $63.0 (changed N/A YoY), while the FY2022 annual figure was $33.3 million, up 11398.52% from the prior year.
• Treasury Shares for Q3 2023 stood at $63.0, down from $16084.0 in the prior quarter.
• The five-year high for Treasury Shares was $289918.0 in Q4 2021, with the low at $63.0 in Q3 2023.
• The 5-year median for Treasury Shares is $205000.0 (2020), against an average of $143357.4.
• The sharpest annual moves came in 2021 and 2022: Treasury Shares soared 41.42% in 2021, then slumped 94.45% in 2022.
• Dianthus Therapeutics' Treasury Shares stood at $205722.0 in 2019, then retreated by 0.35% to $205000.0 in 2020, then surged by 41.42% to $289918.0 in 2021, then plunged by 94.45% to $16084.0 in 2022, then sank by 99.61% to $63.0 in 2023.
• Business Quant data shows DNTH's Treasury Shares at $63.0 in Q3 2023, $16084.0 in Q4 2022, and $289918.0 in Q4 2021.